Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upEvent
Evolving U.S. Patent Strategies: AI Technological Innovation, Challenges in the Chemical and Pharmaceutical Sectors, NPE Litigation, and the Latest Trends in NPE Litigation and at the PTAB Evolving U.S. Patent Strategies: AI Technological Innovation, Challenges in the Chemical and Pharmaceutical Sectors, NPE Litigation, and the Latest Trends in NPE Litigation and at the PTAB
October 30, 2025
Tokyo
Seminar
Evolving Patent Strategies: Recent PTAB Trends, AI Challenges, and Biotech Innovations Evolving Patent Strategies: Recent PTAB Trends, AI Challenges, and Biotech Innovations
May 22, 2025
Tokyo
Hybrid Seminar
Japan Agency for Medical Research and Development Training Japan Agency for Medical Research and Development Training
February 25, 2025
Tokyo
Webinar
Introductory Course on Reviewing English Language Contracts for Pharmaceutical Companies Introductory Course on Reviewing English Language Contracts for Pharmaceutical Companies
January 29, 2025
Webinar
Articles
A Battle of What “A pH of 13 or Higher” Means A Battle of What “A pH of 13 or Higher” Means
August 2024
Intellectual Property ManagementWebinar
General Information on English Contracts for Pharmaceutical Products General Information on English Contracts for Pharmaceutical Products
February 16, 2023
Webinar
Articles
Strategies for Parameter Patents in the United States Strategies for Parameter Patents in the United States
February 1, 2023
Intellectual Property ManagementDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.